Literature DB >> 21910027

Comparison of circadian characteristics for cytotoxic lymphocyte subsets in non-small cell lung cancer patients versus controls.

Gianluigi Mazzoccoli1, Robert B Sothern, Paola Parrella, Lucia A Muscarella, Vito Michele Fazio, Francesco Giuliani, Victoria Polyakova, Igor M Kvetnoy.   

Abstract

Lymphocyte subsets are major cellular components of the adaptive immune response and in most cases show 24-h (circadian) variations in health. In order to determine overall levels and circadian characteristics of cytotoxic natural killer (NK) and T and B lymphocyte subsets, blood samples were collected every 4 h for 24 h from eleven male controls (C) without neoplastic disease and nine men with untreated non-small cell lung cancer (NSCLC) and analyzed for 3 hormones (melatonin, cortisol, and interleukin 2 [IL2]) and for 11 lymphocyte subpopulations classified by cell surface clusters of differentiation (CD) and antigen receptors. Circadian rhythmicity for each variable was evaluated by ANOVA and 24 h cosine fitting and groups compared. Rhythms in melatonin and cortisol (peaks near 01:30 and 08:00 h) indicated identical synchronization to the light-dark schedule and probable persistent entrainment of rhythms for both groups in metabolism or proliferation of healthy tissues normally tightly coupled to the sleep-wake cycle. Twenty-four hours means were significantly higher in NSCLC for CD16, CD25, cortisol, and IL2 and lower for CD8, CD8bright, and γδTCR. A significant circadian rhythm was found in C with daytime peaks for CD8, CD8dim, CD16, Vδ2TCR, and cortisol and nighttime peaks for CD3, CD4, CD20, and melatonin, and in NSCLC, with daytime peaks for CD16, γδTCR, Vδ2TCR and cortisol, and nighttime peaks for CD4, CD25, and melatonin. Thus, NSCLC was associated with significant increases or decreases in proportions for several lymphocyte subsets that may reflect disease development, but peak times were nevertheless similar between C and NSCLC for each variable, suggesting that timed circadian administration (chronotherapy) of immunotherapy and other cancer treatments may improve efficacy due to persistent circadian entrainment of healthy tissues.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21910027     DOI: 10.1007/s10238-011-0153-6

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  66 in total

Review 1.  Molecular pathways linking inflammation and cancer.

Authors:  A Mantovani
Journal:  Curr Mol Med       Date:  2010-06       Impact factor: 2.222

Review 2.  The origin and function of tumor-associated macrophages.

Authors:  A Mantovani; B Bottazzi; F Colotta; S Sozzani; L Ruco
Journal:  Immunol Today       Date:  1992-07

3.  Chronolab: an interactive software package for chronobiologic time series analysis written for the Macintosh computer.

Authors:  A Mojón; J R Fernández; R C Hermida
Journal:  Chronobiol Int       Date:  1992-12       Impact factor: 2.877

4.  Circadian rhythm of leucocytes and lymphocytes subsets and its possible correlation with the function of the autonomic nervous system.

Authors:  S Suzuki; S Toyabe; T Moroda; T Tada; A Tsukahara; T Iiai; M Minagawa; S Maruyama; K Hatakeyama; K Endoh; T Abo
Journal:  Clin Exp Immunol       Date:  1997-12       Impact factor: 4.330

Review 5.  Chronotherapeutic strategy: Rhythm monitoring, manipulation and disruption.

Authors:  Shigehiro Ohdo
Journal:  Adv Drug Deliv Rev       Date:  2010-02-25       Impact factor: 15.470

Review 6.  Chemokines in cancer related inflammation.

Authors:  Paola Allavena; Giovanni Germano; Federica Marchesi; Alberto Mantovani
Journal:  Exp Cell Res       Date:  2010-12-04       Impact factor: 3.905

7.  Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine.

Authors:  Marc Beyer; Matthias Kochanek; Kamruz Darabi; Alexey Popov; Markus Jensen; Elmar Endl; Percy A Knolle; Roman K Thomas; Michael von Bergwelt-Baildon; Svenja Debey; Michael Hallek; Joachim L Schultze
Journal:  Blood       Date:  2005-05-24       Impact factor: 22.113

Review 8.  The B7 family and cancer therapy: costimulation and coinhibition.

Authors:  Xingxing Zang; James P Allison
Journal:  Clin Cancer Res       Date:  2007-09-15       Impact factor: 12.531

9.  Altered time structure of neuro-endocrine-immune system function in lung cancer patients.

Authors:  Gianluigi Mazzoccoli; Gianluigi Vendemiale; Angelo De Cata; Stefano Carughi; Roberto Tarquini
Journal:  BMC Cancer       Date:  2010-06-21       Impact factor: 4.430

10.  Selective mobilization of cytotoxic leukocytes by epinephrine.

Authors:  Stoyan Dimitrov; Tanja Lange; Jan Born
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

View more
  6 in total

Review 1.  Crosstalk between the circadian clock circuitry and the immune system.

Authors:  Nicolas Cermakian; Tanja Lange; Diego Golombek; Dipak Sarkar; Atsuhito Nakao; Shigenobu Shibata; Gianluigi Mazzoccoli
Journal:  Chronobiol Int       Date:  2013-05-22       Impact factor: 2.877

2.  Presence of antigen-specific somatic allelic mutations and splice variants do not predict for immunological response to genetic vaccination.

Authors:  Jordan T Becker; Douglas G McNeel
Journal:  J Immunother Cancer       Date:  2013-05-29       Impact factor: 13.751

3.  Circulating activated immune cells as a potential blood biomarkers of non-small cell lung cancer occurrence and progression.

Authors:  Yingyi Wang; Na Zhou; Rui Zhu; Xiaoyuan Li; Zhao Sun; Yang Gao; Wei Liu; Changting Meng; Yuping Ge; Chunmei Bai; Taisheng Li; Hongsheng Liu
Journal:  BMC Pulm Med       Date:  2021-09-06       Impact factor: 3.317

4.  Time-Dependent Efficacy of Checkpoint Inhibitor Nivolumab: Results from a Pilot Study in Patients with Metastatic Non-Small-Cell Lung Cancer.

Authors:  Abdoulaye Karaboué; Thierry Collon; Ida Pavese; Viviane Bodiguel; Joel Cucherousset; Elda Zakine; Pasquale F Innominato; Mohamed Bouchahda; René Adam; Francis Lévi
Journal:  Cancers (Basel)       Date:  2022-02-11       Impact factor: 6.639

5.  Peripheral immune cell gene expression changes in advanced non-small cell lung cancer patients treated with first line combination chemotherapy.

Authors:  Yung-Che Chen; Chang-Chun Hsiao; Kuang-Den Chen; Yu-Chiang Hung; Ching-Yuan Wu; Chien-Hao Lie; Shih-Feng Liu; Ming-Tse Sung; Chung-Jen Chen; Ting-Ya Wang; Jen-Chieh Chang; Petrus Tang; Wen-Feng Fang; Yi-Hsi Wang; Yu-Hsiu Chung; Tung-Ying Chao; Sum-Yee Leung; Mao-Chang Su; Chin-Chou Wang; Meng-Chih Lin
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

6.  In silico analysis of cell cycle synchronisation effects in radiotherapy of tumour spheroids.

Authors:  Harald Kempf; Haralampos Hatzikirou; Marcus Bleicher; Michael Meyer-Hermann
Journal:  PLoS Comput Biol       Date:  2013-11-14       Impact factor: 4.475

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.